Our data provided evidence supporting the potential of DHA in RA treatment and shed some light on the underlying mechanisms: DHA inhibited the NLRP3 expression through the HIF‐1α and JAK3/STAT3 signaling pathway in macrophages, and as a consequence, the following inflammatory response was prevented. The gene discussed is NLRP3; the disease is rheumatoid arthritis.